{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T09:23:52Z","timestamp":1786785832734,"version":"build-2736575974"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T00:00:00Z","timestamp":1513728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI116228"],"award-info":[{"award-number":["AI116228"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI078799"],"award-info":[{"award-number":["AI078799"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL134539"],"award-info":[{"award-number":["HL134539"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI125109"],"award-info":[{"award-number":["AI125109"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD16CIII\/0002\/0002"],"award-info":[{"award-number":["RD16CIII\/0002\/0002"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14CIII\/00011"],"award-info":[{"award-number":["PI14CIII\/00011"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Redes Tematicas de Investigacion en SIDA, Spanish AIDS Research Network","award":["RD12\/0017\/0029"],"award-info":[{"award-number":["RD12\/0017\/0029"]}]},{"name":"Redes Tematicas de Investigacion en SIDA, Spanish AIDS Research Network","award":["RD16\/0025\/0020"],"award-info":[{"award-number":["RD16\/0025\/0020"]}]},{"name":"ISCIII Fondo de Investigaci\u00f3n Sanitaria y el Fondo Europeo de Desarrollo Regional","award":["PI12\/02283"],"award-info":[{"award-number":["PI12\/02283"]}]},{"name":"ISCIII Fondo de Investigaci\u00f3n Sanitaria y el Fondo Europeo de Desarrollo Regional","award":["PI16\/00684,"],"award-info":[{"award-number":["PI16\/00684,"]}]},{"name":"ISCIII Fondo de Investigaci\u00f3n Sanitaria y el Fondo Europeo de Desarrollo Regional","award":["CPII014\/00025"],"award-info":[{"award-number":["CPII014\/00025"]}]},{"name":"Consejer\u00eda de Salud y Bienestar Social of Junta de Andaluc\u00eda","award":["C-0032\/17"],"award-info":[{"award-number":["C-0032\/17"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,1]]},"DOI":"10.1093\/cid\/cix1111","type":"journal-article","created":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T15:24:39Z","timestamp":1513610679000},"page":"1910-1917","source":"Crossref","is-referenced-by-count":39,"title":["Pegylated Interferon-\u03b1\u2013Induced Natural Killer Cell Activation Is Associated With Human Immunodeficiency Virus-1 DNA Decline in Antiretroviral Therapy\u2013Treated HIV-1\/Hepatitis C Virus\u2013Coinfected Patients"],"prefix":"10.1093","volume":"66","author":[{"given":"St\u00e9phane","family":"Hua","sequence":"first","affiliation":[{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selena","family":"Vigano","sequence":"additional","affiliation":[{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Tse","sequence":"additional","affiliation":[{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ouyang","family":"Zhengyu","sequence":"additional","affiliation":[{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Harrington","sequence":"additional","affiliation":[{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Negron","sequence":"additional","affiliation":[{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Garcia-Broncano","sequence":"additional","affiliation":[{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge"},{"name":"Unit of Viral Infection and Immunity, National Center for Microbiology, Institute of Health Carlos III, Majadahonda, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Marchetti","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Clinic of Infectious and Tropical Diseases, San Paolo Hospital, University of Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Genebat","sequence":"additional","affiliation":[{"name":"Laboratory of Immunovirology, University of Seville, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Leal","sequence":"additional","affiliation":[{"name":"Laboratory of Immunovirology, University of Seville, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Resino","sequence":"additional","affiliation":[{"name":"Unit of Viral Infection and Immunity, National Center for Microbiology, Institute of Health Carlos III, Majadahonda, Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezequiel","family":"Ruiz-Mateos","sequence":"additional","affiliation":[{"name":"Laboratory of Immunovirology, University of Seville, Spain"},{"name":"Clinic Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville, Virgen del Roc\u00edo University Hospital\/Spanish National Research Council (CSIC)\/University of Seville, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Lichterfeld","sequence":"additional","affiliation":[{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge"},{"name":"Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu G","family":"Yu","sequence":"additional","affiliation":[{"name":"Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard, Cambridge"},{"name":"Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,12,20]]},"reference":[{"key":"key\n\t\t\t\t20180626050801_CIT0001","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.tim.2015.01.013","article-title":"Towards an HIV-1 cure: measuring the latent reservoir","volume":"23","author":"Bruner","year":"2015","journal-title":"Trends Microbiol"},{"key":"key\n\t\t\t\t20180626050801_CIT0002","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm.1972","article-title":"HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation","volume":"15","author":"Chomont","year":"2009","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20180626050801_CIT0003","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"key\n\t\t\t\t20180626050801_CIT0004","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nrmicro3449","article-title":"HIV-1 and interferons: who\u2019s interfering with whom","volume":"13","author":"Doyle","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"key\n\t\t\t\t20180626050801_CIT0005","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/infdis\/jit628","article-title":"Hepatitis C therapy with interferon-\u03b1 and ribavirin reduces CD4 T-cell-associated HIV-1 DNA in HIV-1\/hepatitis C virus-coinfected patients","volume":"209","author":"Sun","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180626050801_CIT0006","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1086\/652420","article-title":"Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial","volume":"201","author":"Asmuth","year":"2010","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180626050801_CIT0007","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.antiviral.2015.03.011","article-title":"Hepatitis C therapy with interferon-\u03b1 and ribavirin reduces the CD4 cell count and the total, 2LTR circular and integrated HIV-1 DNA in HIV\/HCV co-infected patients","volume":"118","author":"Jiao","year":"2015","journal-title":"Antiviral Res"},{"key":"key\n\t\t\t\t20180626050801_CIT0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jir.2007.0076","article-title":"Interferon may prevent HIV viral rebound after HAART interruption in HIV patients","volume":"28","author":"Dianzani","year":"2008","journal-title":"J Interferon Cytokine Res"},{"key":"key\n\t\t\t\t20180626050801_CIT0009","first-page":"3544","article-title":"Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response","volume":"119","author":"Jacquelin","year":"2009","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180626050801_CIT0010","first-page":"3556","article-title":"Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys","volume":"119","author":"Bosinger","year":"2009","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180626050801_CIT0011","doi-asserted-by":"crossref","first-page":"e30306","DOI":"10.1371\/journal.pone.0030306","article-title":"Interferon-alpha administration enhances CD8+ T cell activation in HIV infection","volume":"7","author":"Manion","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180626050801_CIT0012","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ni.2229","article-title":"Intrinsic antiviral immunity","volume":"13","author":"Yan","year":"2012","journal-title":"Nat Immunol"},{"key":"key\n\t\t\t\t20180626050801_CIT0013","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1097\/QAD.0000000000000777","article-title":"Lysis of HIV-1-infected autologous CD4+ primary T cells by interferon-alpha-activated NK cells requires NKp46 and NKG2D","volume":"29","author":"Tomescu","year":"2015","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180626050801_CIT0014","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/QAD.0000000000001380","article-title":"IFN-\u03b1 augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation","volume":"31","author":"Tomescu","year":"2017","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180626050801_CIT0015","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.immuni.2014.05.004","article-title":"Type I interferon protects antiviral CD8+ T cells from NK cell cytotoxicity","volume":"40","author":"Xu","year":"2014","journal-title":"Immunity"},{"key":"key\n\t\t\t\t20180626050801_CIT0016","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.immuni.2014.05.003","article-title":"Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1","volume":"40","author":"Crouse","year":"2014","journal-title":"Immunity"},{"key":"key\n\t\t\t\t20180626050801_CIT0017","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nm.3445","article-title":"HIV-1 persistence in CD4+ T cells with stem cell-like properties","volume":"20","author":"Buzon","year":"2014","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20180626050801_CIT0018","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2010.07.041","article-title":"Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients","volume":"54","author":"Sarrazin","year":"2011","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20180626050801_CIT0019","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","article-title":"CD56bright natural killer (NK) cells: an important NK cell subset","volume":"126","author":"Poli","year":"2009","journal-title":"Immunology"},{"key":"key\n\t\t\t\t20180626050801_CIT0020","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.4049\/jimmunol.1100330","article-title":"CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation","volume":"186","author":"B\u00e9ziat","year":"2011","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180626050801_CIT0021","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1172\/JCI93289","article-title":"Clonal expansion of genome-intact HIV-1 in functionally polarized Th1 CD4+ T cells","volume":"127","author":"Lee","year":"2017","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180626050801_CIT0022","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1084\/jem.20170193","article-title":"Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: potential role in latent reservoir dynamics","volume":"214","author":"Hosmane","year":"2017","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20180626050801_CIT0023","doi-asserted-by":"crossref","first-page":"16725","DOI":"10.1073\/pnas.0804192105","article-title":"HIV rebounds from latently infected cells, rather than from continuing low-level replication","volume":"105","author":"Joos","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180626050801_CIT0024","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1097\/QAD.0000000000000478","article-title":"Relationship of HIV reservoir characteristics with immune status and viral rebound kinetics in an HIV therapeutic vaccine study","volume":"28","author":"Li","year":"2014","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180626050801_CIT0025","first-page":"343","article-title":"The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruption","volume":"30","author":"Li","year":"2016","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20180626050801_CIT0026","doi-asserted-by":"crossref","first-page":"e03821","DOI":"10.7554\/eLife.03821","article-title":"HIV-1 DNA predicts disease progression and post-treatment virological control","volume":"3","author":"Williams","year":"2014","journal-title":"Elife"},{"key":"key\n\t\t\t\t20180626050801_CIT0027","doi-asserted-by":"crossref","first-page":"9403","DOI":"10.1073\/pnas.0903107106","article-title":"Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy","volume":"106","author":"Dinoso","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20180626050801_CIT0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000321","article-title":"The effect of raltegravir intensification on low-level residual viremia in HIV-infected patients on antiretroviral therapy: a randomized controlled trial","volume-title":"PLoS Med","author":"Gandhi","year":"2010"},{"key":"key\n\t\t\t\t20180626050801_CIT0029","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1056\/NEJMoa1608243","article-title":"Effect of HIV antibody VRC01 on viral rebound after treatment interruption","volume":"375","author":"Bar","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180626050801_CIT0030","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/cid\/cit813","article-title":"A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapy","volume":"58","author":"Spivak","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180626050801_CIT0031","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/S2352-3018(14)70014-1","article-title":"Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1\/2, single group, clinical trial","volume":"1","author":"Rasmussen","year":"2014","journal-title":"Lancet HIV"},{"key":"key\n\t\t\t\t20180626050801_CIT0032","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/infdis\/jix265","article-title":"Human immunodeficiency virus type 1 persistence following systemic chemotherapy for malignancy","volume":"216","author":"Henrich","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180626050801_CIT0033","doi-asserted-by":"crossref","first-page":"e1005535","DOI":"10.1371\/journal.ppat.1005535","article-title":"Real-time predictions of reservoir size and rebound time during antiretroviral therapy interruption trials for HIV","volume":"12","author":"Hill","year":"2016","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20180626050801_CIT0034","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/infdis\/jiv521","article-title":"Short-term treatment with interferon alfa diminishes expression of HIV-1 and reduces CD4+ T-cell activation in patients coinfected with HIV and hepatitis C virus and receiving antiretroviral therapy","volume":"213","author":"Mor\u00f3n-L\u00f3pez","year":"2016","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180626050801_CIT0035","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1128\/JVI.00451-16","article-title":"Interferon alpha subtype-specific suppression of HIV-1 infection in vivo","volume":"90","author":"Lavender","year":"2016","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180626050801_CIT0036","doi-asserted-by":"crossref","first-page":"10201","DOI":"10.1128\/JVI.00419-07","article-title":"Alpha interferon enhances TRIM5alpha-mediated antiviral activities in human and rhesus monkey cells","volume":"81","author":"Sakuma","year":"2007","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180626050801_CIT0037","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nm.4124","article-title":"Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation","volume":"22","author":"Li","year":"2016","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20180626050801_CIT0038","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag1809","article-title":"Delayed differentiation of potent effector CD8(+) T cells reducing viremia and reservoir seeding in acute HIV infection","volume":"9","author":"Takata","year":"2017","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t20180626050801_CIT0039","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.4049\/jimmunol.176.8.4682","article-title":"Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during cross-priming","volume":"176","author":"Le Bon","year":"2006","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180626050801_CIT0040","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1002\/eji.201040664","article-title":"Effects of IFN-\u03b1 as a signal-3 cytokine on human na\u00efve and antigen-experienced CD8(+) T cells","volume":"40","author":"Hervas-Stubbs","year":"2010","journal-title":"Eur J Immunol"},{"key":"key\n\t\t\t\t20180626050801_CIT0041","doi-asserted-by":"crossref","first-page":"10176","DOI":"10.1128\/JVI.01484-15","article-title":"Innate immune activity correlates with CD4 T cell-associated HIV-1 DNA decline during latency-reversing treatment with panobinostat","volume":"89","author":"Olesen","year":"2015","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180626050801_CIT0042","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00647-17","article-title":"Control of the HIV-1 DNA reservoir is associated in vivo and in vitro with NKp46\/NKp30 (CD335 CD337) inducibility and interferon gamma production by transcriptionally unique NK cells","volume":"91","author":"Marras","year":"2017","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180626050801_CIT0043","doi-asserted-by":"crossref","first-page":"e1005472","DOI":"10.1371\/journal.ppat.1005472","article-title":"Integrated and total HIV-1 DNA predict ex vivo viral outgrowth","volume":"12","author":"Kiselinova","year":"2016","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20180626050801_CIT0044","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1172\/JCI89488","article-title":"Targeting type I interferon-mediated activation restores immune function in chronic HIV infection","volume":"127","author":"Zhen","year":"2017","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180626050801_CIT0045","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1172\/JCI90745","article-title":"Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs","volume":"127","author":"Cheng","year":"2017","journal-title":"J Clin Invest"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/66\/12\/1910\/25084671\/cix1111.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T02:15:27Z","timestamp":1570500927000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/66\/12\/1910\/4767848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,20]]},"references-count":45,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12,20]]},"published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cix1111","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,6,15]]},"published":{"date-parts":[[2017,12,20]]}}}